Early phase II trial of human rotavirus vaccine candidate RV3.
Barnes GL, Lund JS, Mitchell SV, De Bruyn L, Piggford L, Smith AL, Furmedge J, Masendycz PJ, Bugg HC, Bogdanovic-Sakran N, Carlin JB, Bishop RF.
Barnes GL, et al.
Vaccine. 2002 Jul 26;20(23-24):2950-6. doi: 10.1016/s0264-410x(02)00235-9.
Vaccine. 2002.
PMID: 12126907
Clinical Trial.